The demand for medical marijuana in Germany has skyrocketed since it was legalised in March last year, placing a greater burden on the country’s health insurance providers to cover the cost of prescriptions.
A new report published by German health insurance company Techniker-Krankenkasse, or TK, and the University of Bremen found that as of February nearly 16,000 patients nationwide had applied to be reimbursed for medical marijuana costs, compared to around 1,100 before the law came into effect.
The authors of the “Cannabis Report” also question the medical benefits of cannabis, often touted as an “herbal wonder drug.”
“It is unclear which groups of patients cannabis helps in which dose — and in which form it should best be administered,” University of Bremen professor and author of the study Gerd Glaseke said, according to Weser Kurier.
– Read the entire article at Business Insider.
